Navigation Links
Biofisica Obtains $2.3 Million in Financing From Investors
Date:4/21/2008

ATLANTA, April 21 /PRNewswire/ -- Biofisica Inc., an Atlanta-based company specializing in wound care therapy, today announced that it has obtained a commitment of $2.3 million in financing from investors. The funding will support Biofisica's continued marketing efforts in the UK and ongoing planning initiatives in the U.S.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070808/CLW014LOGO )

The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors.

"We are very pleased that our investors continue to show a tremendous vote of confidence for the progress that we're making with our business plan and the recognition that POSiFECT(R) serves a critical need in the wound care market," said Rafael Andino, founder of Biofisica.

POSiFECT is the first medical device available that combines two technologies - moist wound-care dressing and electrical stimulation - in a fully disposable, easy-to-use, sterile dressing that facilitates the normal healing process. Clinical research has shown that POSiFECT accelerates healing in difficult to heal or non-healing chronic wounds. The product launched last year in the UK and has since had excellent clinical response in a post market surveillance study. POSiFECT also has been approved for marketing in Canada. The product is not yet available in the U.S.

"We believe that Biofisica's POSiFECT technology represents an innovative and effective approach to the treatment of chronic wounds," said Dion Madsen, managing director of Physic Ventures, the General Partner for Unilever Technology Ventures. "Chronic wounds are currently poorly treated and this technology approach represents a very convenient and cost effective therapy that has the potential to improve the lives of millions of chronic wound care patients."

About Biofisica

Biofisica Inc., ( http://www.biofisica.com ) is a high-tech wound care company that was founded in Atlanta, Georgia (USA) to develop new solutions within the tissue engineering market to specifically address chronic wound healing. Biofisica's wound care technology is uniquely positioned to provide chronic wound solutions to the wound care market - a global market that is estimated in excess of $12 billion.

The company also has offices in the United Kingdom. Biofisica was named as one of Georgia's top 40 technology companies in 2006 by the Technology Association of Georgia.


'/>"/>
SOURCE Biofisica Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
2. Botaneco obtains $2.4 million in funding from AVAC
3. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
4. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
5. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
6. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
7. PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations
8. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
9. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
10. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
11. CrossFire Beilstein Database Exceeds Ten Million Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... ... related applications were the focus of researchers, engineers, product developers, and industry suppliers ... Anaheim. , Sponsored by SPIE, the international society for optics and photonics ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... to nourishing a range of emerging bio and technology start-ups, is hosting “Celebration ... 2017. This double event will start with libations and networking at 3:30 p.m. ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... this new webinar will explore challenging patient cases when screening for direct oral ... there may be a need for bridging parental anticoagulation especially for those at ...
(Date:4/20/2017)... INDIANAPOLIS , April 20, 2017  Eli Lilly ... Phase 2 data evaluating galcanezumab for the prevention of ... meeting, which will take place April 22-28, 2017, in ... will present four abstracts at AAN, including safety and ... and factors associated with a reduction in monthly migraine ...
Breaking Biology Technology:
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):